个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Lingyuan Huang[1] ; Chanjuan Zhao[2] ; Kai Sun[1] ; Dandan Yang[1] ; Linxia Yan[1] ; Dan Luo[1] ; Jinli He[1] ; Xuemei Hu[1] ; Rong Wang[1] ; Xiaofei Shen[1] ; Ning Xiao[4,*2] ; Zhendong Zhong[3,*1] ;
机构： [1]Chengdu Lilai Biotechnology Co., Ltd, Chengdu, China [2]Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, SiChuan University, Chengdu, China [3]Institute of Laboratory Animals of Sichuan Academy of Medical Science, Sichuan Provincial People's Hospital, Chengdu, China [4]Health Management Center & Physical Examination Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China
出处：
DOI： 10.1002/cbf.3489
ISSN：

关键词： Claudin-6 EGFR AKT mTOR pathway hepatocellular carcinoma invasion migration proliferation

摘要：
Accumulating evidence showed that the claudin-6 (CLDN6) expression was abnormal in many cancers, while its expression and biological functions in hepatocellular carcinoma (HCC) is still unclear. The present study demonstrated that CLDN6 was upregulated in HCC tissues compared with tumour-adjacent tissues. CLDN6 silencing was significantly inhibited proliferation, migration, and invasion of HepG2 cells. Meanwhile, downregulation of CLDN6 remarkably inhibited the activation of EGFR/AKT/mTOR signalling pathway. Interestingly, the effect of CLDN6 overexpression on HepG2 cell proliferation and invasion could be inhibited by EGFR/AKT/mTOR signalling pathway inhibitor (AG1478). Significance of the study These findings suggested that CLDN6 may act as an oncogene in HCC and improve HepG2 cell proliferation, migration, and invasion may via EGFR/AKT/mTOR signalling pathway.

基金：
Sichuan Health and Family Planning Commission Research Project [17PJ485]
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类 | 4 区 生物学
小类 | 4 区 生化与分子生物学 4 区 细胞生物学
最新[2023]版：
大类 | 3 区 生物学
小类 | 4 区 生化与分子生物学 4 区 细胞生物学
JCR分区：
出版当年[2020]版：
Q3 CELL BIOLOGY Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版：
Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 CELL BIOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者：
第一作者机构： [1]Chengdu Lilai Biotechnology Co., Ltd, Chengdu, China
共同第一作者：
通讯作者：
通讯机构： [3]Institute of Laboratory Animals of Sichuan Academy of Medical Science, Sichuan Provincial People's Hospital, Chengdu, China [4]Health Management Center & Physical Examination Center, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China [*1]Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, No. 32, West Second Section of the First Ring Road, Qingyang District, Chengdu 610000, China [*2]Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, No. 32,West Second Section of the First Ring Road, Qingyang District, Chengdu, China
推荐引用方式(GB/T 7714)：
Lingyuan Huang,Chanjuan Zhao,Kai Sun,et al.Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma[J].CELL BIOCHEMISTRY AND FUNCTION.2020,38(5):541-548.doi:10.1002/cbf.3489.
APA：
Lingyuan Huang,Chanjuan Zhao,Kai Sun,Dandan Yang,Linxia Yan...&Zhendong Zhong.(2020).Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma.CELL BIOCHEMISTRY AND FUNCTION,38,(5)
MLA：
Lingyuan Huang,et al."Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma".CELL BIOCHEMISTRY AND FUNCTION 38..5(2020):541-548

相关文献

[1]Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway [2]SOS1 regulates HCC cell epithelial-mesenchymal transition via the PI3K/AKT/mTOR pathway [3]S100 Calcium Binding Protein A10, A Novel Oncogene, Promotes the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma. [4]Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma [5]PPIP5K2 Facilitates Proliferation and Metastasis of Non-Small Lung Cancer (NSCLC) through AKT Signaling Pathway [6]Alnustone inhibits the growth of hepatocellular carcinoma via ROS- mediated PI3K/Akt/mTOR/p70S6K axis. [7]Polyphyllin II inhibits liver cancer cell proliferation, migration and invasion through downregulated cofilin activity and the AKT/NF-κB pathway. [8]CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathway [9]Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway [10]Parthenolide Inhibits the Proliferation of MDA-T32 Papillary Thyroid Carcinoma Cells in Vitro and in Mouse Tumor Xenografts and Activates Autophagy and Apoptosis by Downregulation of the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Signaling Pathway

资源点击量：43378 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号